Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
06/2002
06/19/2002EP1214040A1 Extracts of orange peel for prevention and treatment of cancer
06/19/2002CN1354743A 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation
06/19/2002CN1086290C Composition for treating condyloma acuminata
06/18/2002US6407073 Use of coumarin derivatives for the treatment of digestive tract disorders
06/13/2002WO2002046180A1 Klainetin and derivatives thereof, method for their production and the use of the same
06/13/2002WO2001083438A3 New gamma selective retinoids
06/13/2002US20020072620 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
06/13/2002US20020072619 Reacting trimethylhydroquinone with isophytol or phytol in the presence of a bis(perfluorinated hydrocarbyl sulphonyl)imide catalyst or a metal salt thereof in organic solvent; recovering (all-rac)- alpha -tocopherol
06/13/2002US20020072591 Recovery of isoflavones from soy molasses
06/13/2002US20020071857 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
06/13/2002DE10051427C1 Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte A method for producing a tetrahydrocannabinol and cannabidiol-containing extract of the cannabis plant material, as well as cannabis extracts
06/13/2002CA2430466A1 Klainetin and derivatives thereof, method for their production and the use of the same
06/12/2002EP1212619A1 Substrates and screening methods for transport proteins
06/12/2002EP1212316A2 Benzopyrans and benzothiopyrans as rar selective retinoid agonists
06/12/2002EP1212315A1 Novel chalcones
06/12/2002EP1212314A1 Benzopyran derivative
06/12/2002EP1212313A1 7-carboxy-flavone derivatives, preparation method and therapeutic use
06/12/2002EP1212312A1 Novel derivatives of flavones, xanthones and coumarins
06/12/2002EP1212311A1 Chalcone coumarins
06/12/2002EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
06/12/2002EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
06/12/2002EP0977747B1 Photoactive coumarin derivatives
06/12/2002EP0907641B1 Fluoroionophores and their use in optical ion sensors
06/12/2002EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action
06/12/2002EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/12/2002EP0873122B1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
06/12/2002EP0656894B2 Isolation of tocopherol and sterol
06/11/2002US6403812 Detecting multiple target substances in same sample
06/11/2002US6403811 Recovery of chroman derivatives
06/11/2002US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
06/11/2002US6403594 Urogential infections, etc
06/06/2002WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels
06/06/2002WO2002044140A1 Practical and efficient synthetic method of retinoic acid and its derivatives
06/06/2002WO2001094333A3 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives
06/06/2002WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity
06/06/2002US20020068757 Administering biflavanoid selected from robustaflavone, amentoflavone, agathisflavone, volkensiflavone, rhusflavanone, succedaneaflavanone, morelloflavone etc. and atleast one antiviral agent to treat viral infection
06/06/2002US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases
06/06/2002US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis.
06/06/2002US20020068738 Cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus, especially HIV.
06/06/2002US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation.
06/06/2002US20020068332 Generating expression vector coding polyketide synthases; generate nucleotide sequences, obtain cells, transform cells, recover polytketide synthases
06/06/2002CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels
06/05/2002EP1211251A1 Chromone derivatives, process for the preparation of the same and uses thereof
06/05/2002EP1210342A1 The use of fluorescein aryl ethers in high throughput cytochrome p450 inhibition assays
06/05/2002EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease
06/04/2002US6399798 Method of preparing alkylated salicylamides
06/04/2002US6399791 Photochromism
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399774 Compounds having activity as inhibitors of cytochrome P450RAI
06/04/2002US6399656 Using a benzopyran-3-carboxamide compound
06/04/2002US6399654 Biflavanoids and derivatives thereof as antiviral agents
06/04/2002US6399653 Ring fused dihydropyrans, process for preparation and use thereof
06/04/2002US6399542 Alkoxyimino-substituted bicyclic compounds compositions containing the same and method of making such compounds
06/04/2002US6399382 Synthase catalyst biosynthesis
06/04/2002US6399223 Compound for use in organic EL device and organic EL device
06/04/2002US6399072 Reverse addiction with isoflavones, lignans, sapoins, catechins and phenol acids
06/04/2002US6398987 Photochromic; strong colorability; grey; brown; rapid discoloration kinetics; contact lenses; solar protection glasses; camera optics
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042287A1 Method for chromatographic preparation of tocotrienol
05/30/2002WO2002042286A1 Method for continuously acylating chromanol ester derivatives
05/30/2002WO2002042285A1 Novel process for the preparation of 4-benzoylamino chroman derivatives
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002041910A2 Methods and compositions for the treatment of diseases of the eye
05/30/2002WO2002004444A3 Heterocycle carboxamides as antiviral agents
05/30/2002WO2001064646A3 Hydrazones and analogs as cholesterol lowering agents
05/30/2002WO2001023352A8 Preparation of sulfonyl imine compounds
05/30/2002WO2000024411A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
05/30/2002US20020065299 Administering for therapy of mitochondria medited disease
05/30/2002US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases
05/30/2002EP1143986A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002CA2427334A1 Methods and compositions for the treatment of diseases of the eye
05/29/2002EP1209156A2 Process for extracting pure vitamin E-acetate or pure tocopheroles by rectification to remove lower and higher boiling contaminants
05/29/2002EP1208095A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
05/29/2002EP1207862A2 Arthritis treatment
05/29/2002EP1117656B1 Grey colouring photochromic fused pyrans
05/29/2002EP0857066B1 Use of nitroflavonoids for the treatment of anxiety
05/29/2002EP0799023B1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
05/29/2002DE10028443C1 Production of optically active 3,3-diaryl-propylamine derivatives comprises six step process from 4-hydroxybenzoic acid or alkyl 4-hydroxybenzoate and cinnamic acid
05/29/2002CN1351583A Oxyalkylene-substituted aminophenol intermediate
05/29/2002CN1351012A Process for extracting high-purity tea polyphenol, theapigment and theine
05/29/2002CN1351011A Process for continuously synthesizing coumarin
05/28/2002US6395915 Reverse phase liquid chromatography with elution
05/28/2002US6395909 Drugs for anticonvulsants
05/28/2002US6395367 Electroconductivity
05/28/2002US6395280 Deodorant agents for oral use for discharges and method for relieving odor of discharges
05/28/2002US6395279 Mixture of at least two phytochemicals including isoflavones, lignins, saponins, catechins, and phenolic acids
05/28/2002CA2222467C Novel derivatives of benzopyrane, process for preparing them and pharmaceutical compositions containing them
05/23/2002WO2002040701A2 Energy transfer labels with mechanically linked fluorophores
05/23/2002WO2002039960A2 Cosmetic method of treating skin
05/23/2002WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
05/23/2002US20020061924 Antiischemic agents, improving deformability of erythrocyte membrane and peripheral circulation
05/23/2002DE10056400A1 Galenische Formulierung Drug formulation
05/22/2002EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones
05/22/2002EP1169304A4 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation
05/22/2002EP0804501B1 Microcapsules containing a stabiliser mixture made from chromane derivatives, inert organic solvents and organic phosphites or phosphonites and/or amines.
05/22/2002EP0729463B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/22/2002EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors